Categories: Entertainment

CCTV+: China Up Close: Zhejiang Tour Explores Deqing

BEIJING, Aug. 15, 2025 /PRNewswire/ — From August 8 to 10, 2025, the “China Up Close Series: Zhejiang Tour” brought a contingent of nearly 70 journalists and editors from South Korea, Spain, Bulgaria, and Iceland to Deqing, a county in Zhejiang province. Alongside CGTN (China Global Television Network), they trained their cameras and notebooks on the area, aiming to capture its landscapes, history and cultural rhythms for audiences abroad.

- Advertisement -

Video – https://mma.prnewswire.com/media/2750529/China_Up_Close_Zhejiang_Tour_Explores_Deqing.mp4

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cctv-china-up-close-zhejiang-tour-explores-deqing-302530764.html

- Advertisement -
PRNW Agency

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

8 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

8 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

8 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

10 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

11 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

11 hours ago